Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk (no)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified February 2013 by Hillel Yaffe Medical Center
Sponsor:
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01800110
First received: February 19, 2013
Last updated: February 25, 2013
Last verified: February 2013

February 19, 2013
February 25, 2013
April 2013
April 2015   (final data collection date for primary outcome measure)
anti oxidant level in human breast milk [ Time Frame: at least one year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01800110 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk
Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk

Many medicinal effects of Pomegranate juices are already known. Mainly known for its anti-viral, anti-bacterial and anti-oxide tendency of pomegranate juice.

Many studies which have demonstrated antioxidant activity of pomegranate juice in the blood and blood cells were published.

In addition, published studies have demonstrated the anti-oxidant activity which inhibit the development of atherosclerosis and stroke, even in patients with diabetes, and its effect of decreasing systolic blood pressure in patients with systemic hypertension.

The purpose of the work is to examine the effect of drinking pomegranate juice on the level of anti-oxidants in human breast milk.

the effect of pomegranate juice consumption on breast milk anti oxidants level.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Basic Science
Breast Milk
Dietary Supplement: pomegranate juice
Experimental: 2
label I- 200 cc pomegranate juice once daily for 6 weeks post partum. label II- control group, no placebo is givening.
Intervention: Dietary Supplement: pomegranate juice
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
40
Not Provided
April 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • lactating woman

Exclusion Criteria:

  • pomegranate allergy
  • diabetes mellitus
  • use of other Dietary Supplement
Female
16 Years to 45 Years
Yes
Not Provided
 
NCT01800110
0013-13
Yes
Hillel Yaffe Medical Center
Hillel Yaffe Medical Center
Not Provided
Not Provided
Hillel Yaffe Medical Center
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP